0001127602-20-019949.txt : 20200617 0001127602-20-019949.hdr.sgml : 20200617 20200617181149 ACCESSION NUMBER: 0001127602-20-019949 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200617 FILED AS OF DATE: 20200617 DATE AS OF CHANGE: 20200617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SUGAR RONALD D CENTRAL INDEX KEY: 0001216519 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37702 FILM NUMBER: 20970770 MAIL ADDRESS: STREET 1: 10877 WILSHIRE BLVD. STREET 2: SUITE 1650 CITY: LOS ANGELES STATE: CA ZIP: 900274 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-06-17 0000318154 AMGEN INC AMGN 0001216519 SUGAR RONALD D ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 1 Common Stock 2020-06-17 4 M 0 1000 54.69 A 16576 D Common Stock 2020-06-17 4 S 0 1000 228.54 D 15576 D Nqso (Right to Buy) 54.69 2020-06-17 4 M 0 1000 0 D 2012-04-25 2021-04-25 Common Stock 1000 7000 D The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1. These shares include 1,913 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. /s/ Ronald D. Sugar 2020-06-17